Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Operations (Unaudited)

v3.19.3
Consolidated Statement of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Details        
Revenues $ 403,012 $ 6,224 $ 513,161 $ 28,646
Cost of goods sold 326,276 3,175 418,298 7,164
Gross profit (loss) 76,736 3,049 94,863 21,482
Operating Expenses:        
Research and development expenses 426,665 350,588 1,950,981 1,701,986
Selling, general and administrative 763,801 587,448 3,393,521 2,630,004
Depreciation 839 839 2,517 2,517
Total operating expenses 1,191,305 938,875 5,347,019 4,334,507
Loss from operations (1,114,569) (935,826) (5,252,156) (4,313,025)
Other (Income) expenses:        
Unrealized gain on marketable securities (135,320) 0 (273,720) 0
Realized gain on marketable securities (190,460) 0 (190,460) 0
Amortization of Debt Discount 18,870 193,262 56,195 998,736
Loss (gain) on extinguishment of debt 0 114,723 0 114,723
Interest expense 55,959 89,885 167,275 349,270
Total other (income) expenses (250,951) 397,870 (240,710) 1,462,729
Loss before provision of income tax (863,618) (1,333,696) (5,011,446) (5,775,754)
Provision for income tax 0 0 0 0
Net Income (Loss) Attributable to Parent (863,618) (1,333,696) (5,011,446) (5,775,754)
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS $ (863,618) $ (1,333,696) $ (5,011,446) $ (5,775,754)
Loss per common share - basic and diluted $ (0.01) $ (0.02) $ (0.08) $ (0.10)
Weighted average common shares outstanding - basic and diluted 62,490,798 57,944,134 61,459,631 52,866,871